Mutant glutamate-cysteine ligase and method for manufacturing gamma-glutamyl-valyl-glycine
US-2016326510-A1 · Nov 10, 2016 · US
US10508295B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10508295-B2 |
| Application number | US-201615234119-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2016 |
| Priority date | Mar 5, 2014 |
| Publication date | Dec 17, 2019 |
| Grant date | Dec 17, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
γ-Glu-Val synthetase suitable for generating γ-Glu-Val, and a method for producing γ-Glu-Val-Gly using the same are provided. By using γ-Glu-Val synthetase showing a ratio of γ-glutamylvaline synthetase activity to γ-glutamylglycine synthetase activity of 2.0 or higher, such as γ-Glu-Val synthetase of Kocuria rosea (AJ3132), γ-Glu-Val-Gly is produced from Glu, Val, and Gly as raw materials.
Opening claim text (preview).
The invention claimed is: 1. A method for producing γ-Glu-Val-Gly and/or a salt thereof, the method comprising: contacting a protein and glutathione synthetase with Glu, Val, and Gly to produce γ-Glu-Val-Gly; and collecting the produced γ-Glu-Val-Gly, wherein the protein comprises an amino acid sequence having at least 97% sequence identity to the amino acid sequence of SEQ ID NO: 6, 10, or 16, and has γ-glutamylvaline synthetase activity, and a ratio of γ-glutamylvaline synthetase activity of the protein to γ-glutamylglycine synthetase activity of the protein is 15 or higher. 2. The method according to claim 1 , wherein the protein is purified. 3. The method according to claim 1 , wherein the protein is immobilized. 4. The method according to claim 1 , wherein the contacting of the protein and glutathione synthetase is carried out in the presence of ATP. 5. The method according to claim 1 , wherein the ratio of γ-glutamylvaline synthetase activity of the protein to γ-glutamylglycine synthetase activity of the protein is 20 or higher. 6. The method according to claim 1 , wherein the protein is contained in a culture broth of a microorganism having the protein, cultured cells of the microorganism, or a processed product of the cultured cells. 7. The method according to claim 1 , wherein the protein and the glutathione synthetase are contained in a culture broth of a microorganism having the protein and the glutathione synthetase, cultured cells of the microorganism, or a processed product of the cultured cells. 8. The method according to claim 6 , wherein the microorganism has been modified so that γ-glutamyltransferase activity is reduced as compared to γ-glutamyltransferase activity in a corresponding wild type of the microorganism. 9. The method according to claim 6 , wherein the microorganism is Escherichia coli. 10. The method according to claim 7 , wherein the microorganism has been modified so that γ-glutamyltransferase activity is reduced as compared to γ-glutamyltransferase activity in a corresponding wild type of the microorganism. 11. The method according to claim 7 , wherein the microorganism is Escherichia coli. 12. The method according to claim 1 , wherein the protein has an amino acid sequence having at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 6, 10, or 16, and has γ-glutamylvaline synthetase activity. 13. The method according to claim 1 , wherein the protein has the amino acid sequence of SEQ ID NO: 6, 10, or 16. 14. The method according to claim 1 , wherein an amount of γ-Glu-Val-Gly produced in the contacting is greater than an amount of γ-Glu-Gly-Gly produced in the contacting. 15. The method according to claim 1 , wherein a total amount of γ-Glu-Val and γ-Glu-Val-Gly produced in the contacting is greater than a total amount of γ-Glu-Gly and γ-Glu-Gly-Gly produced in the contacting. 16. The method according to claim 1 , wherein the glutathione synthetase is a protein encoded by the gshB gene of Escherichia coli or the GSH2 gene of Saccharomyces cerevisiae. 17. The method according to claim 13 , wherein the glutathione synthetase is a protein encoded by the gshB gene of Escherichia coli or the GSH2 gene of Saccharomyces cerevisiae. 18. The method according to claim 1 , wherein the glutathione synthetase has the amino acid sequence of SEQ ID NO: 28. 19. The method according to claim 13 , wherein the glutathione synthetase has the amino acid sequence of SEQ ID NO: 28.
having a known sequence of two or more amino acids, e.g. glutathione · CPC title
Glutamate-cysteine ligase (6.3.2.2) · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
Ligases (6) · CPC title
containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.